The effects of neoadjuvant chemotherapy and interval debulking surgery on body composition in patients with ovarian cancer.
John VitarelloMarcus D GoncalvesQin C ZhouAlexia IasonosDarragh F HalpennyAndrew PlodkowskiEmily SchwitzerJennifer J MuellerOliver ZivanovicLee W JonesKaren A CadooJason A KonnerPublished in: JCSM clinical reports (2020)
Skeletal muscle volume was significantly reduced in patients undergoing NACT for ovarian cancer. Non-overweight patients were more likely to achieve CGR if they had lower skeletal muscle volume. Use of volumetric-based measurement for ascertaining body composition should be explored further.
Keyphrases
- body composition
- neoadjuvant chemotherapy
- skeletal muscle
- resistance training
- bone mineral density
- patients undergoing
- end stage renal disease
- locally advanced
- lymph node
- insulin resistance
- ejection fraction
- sentinel lymph node
- newly diagnosed
- minimally invasive
- chronic kidney disease
- peritoneal dialysis
- prognostic factors
- coronary artery bypass
- physical activity
- weight loss
- coronary artery disease
- rectal cancer
- radiation therapy
- body mass index
- atrial fibrillation
- percutaneous coronary intervention
- weight gain
- acute coronary syndrome
- adipose tissue
- patient reported